MBRX·60855D408·US·equity·Healthcare - Biotechnology-13D/G
MBRX (MOLECULIN BIOTECH INC) is held by 9 institutional investors as of Q1 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($74,033), Rockefeller Capital Management L.P. ($10,124), UBS Group AG ($7,807). Net institutional sentiment: Mixed.
See how MBRX's score breaks down across 4 SEC sources
Data sourced from four SEC data sources: 13F, Form 4, 13D/13G, and STOCK Act. Not financial advice. Full disclaimer